Phase 3 Macular Degeneration Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are between 8 and 45 years old (inclusive) at the time of screening
• If you are a woman who could become pregnant, or a man whose partner could become pregnant, you must be willing to use approved contraception methods from consent until a set period after the last dose (confirm with trial site for exact timeframes)
• You have been clinically diagnosed with the typical inherited (autosomal recessive) form of Stargardt macular dystrophy
• You have a genetic test report from an accredited organisation confirming you carry the disease-causing gene mutation
• You are willing to sign and date the required consent forms (or assent forms, if appropriate for your age)

Who may not be able to join:

• You have taken vitamin A supplements, beta-carotene supplements, liver-based products, or prescription retinoid medications within the 30 days before joining the trial
• You are currently breastfeeding, pregnant, have a positive pregnancy test at screening or at the start of the trial, or plan to become pregnant during the study — or you are a man who plans to father a child during the study
• You have previously taken part in a gene therapy, cell therapy, or device study to treat Stargardt disease (unless you can confirm you were in a placebo group with no surgery), or you have taken part in a drug study to treat Stargardt disease within the past 6 months
• You have taken part in a study of any other investigational drug or device recently (the exact timeframe depends on the drug or device involved — confirm with trial site)
• You plan to join any other drug or device study while this trial is ongoing

Important: Always verify eligibility with the trial site directly before applying.